共 25 条
[1]
Dofetilide, a new class Ⅲ antiarrhythmic agent. Lenz TL,Hilleman DE. Pharmacotherapy . 2000
[2]
Effects of procainamide on the defibrillation threshold in man(abtract). Marchlinski FE,Flores B. Circulation . 1988
[3]
Which strategy is"best"after myocardial infarction?The beta-blocker strategy plus implantable cardioverter defibrillator trial: Rationale and study design. Raviele A,Bongiorni MG,Brignole M,et al. The American Journal of Cardiology . 1999
[4]
Effect of sotalol on ventricular fibrillation and defibrillation in humans. Dorian P,Newman D. The American Journal of Cardiology . 1993
[5]
Dl and D sotalol decrease defibrillation energy requirements. Wang M,Dorian P. Pacing and Clinical Electrophysiology . 1989
[6]
Increased pacing threshold after an automatic defibrillator shocks in dogs: Effects of Class Ⅰ and Class Ⅱ antiarrhythmic drugs. Guarnieri T,Datorre SD,Bondke H. Pacing and Clinical Electrophysiology . 1988
[7]
Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure. Torp-Pedersen C,Moller M,Kober L,et al. European Heart Journal . 2000
[8]
Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE Trial). Dolak GL for the CASCADE Investigators. The American Journal of Cardiology . 1994
[9]
Drug device interactions: Clinical Considerations. Reiffel JA. Coromilas JM,Zimmermann JM,et al. Pacing and Clinical Electrophysiology . 1985
[10]
Effects of chronic amiodarone therapy on defibrillation threshold. Jung W,Manz M,Pizzulli L,et al. The American Journal of Cardiology . 1992